Latest Top 20 Read Articles

1.EpiPen® Pricing – Evidence of a systemic problem with drug pricing in the USA

Shruti S Costales

Journal of Generic Medicines

Volume 14 Issue 1, doi: 10.1177/1741134316680391

2.Generic portfolio management: A paradigm for minimizing risk and maximizing value

Kinjal Suchak, Lisa J Murray

Journal of Generic Medicines

Volume 13 Issue 2, doi: 10.1177/1741134316677850

3.A comparison of mechanisms for setting generic drug prices in Canada

Aidan Hollis, Paul Grootendorst

Journal of Generic Medicines

Volume 13 Issue 1, doi: 10.1177/1741134316669967

4.Amgen v. Sanofi: Can an injunction contrary to the public health interest ever properly be granted?

Frederick Howard Rein, Aviv A. Zalcenstein, Kathleen McGuinness\

Journal of Generic Medicines

Volume 14 Issue 2, doi: 10.1177/1741134318755429

5. Compulsory licensing of drug products in developing countries

Satish Saroha, Deepak Kaushik, Arun Nanda

Journal of Generic Medicines

Volume 12 Issue 3–4, doi: 10.1177/1741134313503827

6. Physicians’ loyalty to branded medicines in low-middle-income countries: A structural equation modelling

Gholamhossein Mehralian, Zahra Sharif, Nazila Yousefi, Mahdi Akhgari

Journal of Generic Medicines

Volume 13 Issue 1, doi: 10.1177/1741134316673227

7. Combatting counterfeit drugs: Case studies of Cambodia, Vietnam and Thailand

Jakkrit Kuanpoth

Journal of Generic Medicines

Volume 14 Issue 1, doi: 10.1177/1741134317728403

8. The Falsified Medicines Directive: How to secure your supply chain

G Smith, JA Smith, DA Brindley

Journal of Generic Medicines

Volume 11 Issue 3–4, doi: 10.1177/1741134315588986

9. Monopoly and public health in the medication market: The case of sofosbuvir

Paolo Piergentili

Journal of Generic Medicines

Volume 13 Issue 3, doi: 10.1177/1741134317705691

10. Generic and biosilimilar medicines use and expenditure: A report from the National Observatory on the Use of Medicines (OsMed) of the Italian Medicines Agency (AIFA)

Alessandro Monaco, Federica Mammarella, Agnese Cangini, Roberto Marini, Alessandra Marengoni, Pierluigi Russo, Sergio Pecorelli, Luca Pani

Journal of Generic Medicines

Volume 12 Issue 2, doi: 10.1177/1741134315618535

11. Physical properties of lansoprazole orally disintegrating tablets

Sumio Chono, Katsuki Nakamura, Megumi Matsui

Journal of Generic Medicines

Volume 13 Issue 1, doi: 10.1177/1741134316673226

12. ‘New Federal Trade Secret Legislation – The “Defend Trade Secrets Act”’

Jeffrey H. Handelsman

Journal of Generic Medicines

Volume 13 Issue 1, doi: 10.1177/1741134316665438

13. Compulsory licences on pharmaceutical patents in India: A short article

Sandeep K. Rathod

Journal of Generic Medicines

Volume 13 Issue 3, doi: 10.1177/1741134317691804

14.Evaluating patients' perception towards generic and branded medicines: A segmentation approach

Md Moddassir Alam, Arun Mittal, Deepak Chawla

Journal of Generic Medicines

Volume 13 Issue 4, doi: 10.1177/1741134317737925

15.Pilot testing on safety performance among healthcare professionals

HN Au Yong, K Usmonov, Charles Ramendran SPR, GG Yeoh, L Surienty

Journal of Generic Medicines

doi: 10.1177/1741134318776702

16.The 2011 Canada-European Union Comprehensive Economic and Trade Agreement: an economic impact assessment of the EU’s proposed pharmaceutical intellectual property provisions

P Grootendorst, A Hollis

Journal of Generic Medicines

Volume 8 Issue 2, doi: 10.1177/1741134311408275

17. Implementation of Question-based Review in support of Quality by Design streamlining the US FDA’s review process

Alisha Desai, Jayanta Kumar Maji, Kanhoba Walavalkar, Priti J Mehta

Journal of Generic Medicines

doi: 10.1177/1741134318779236

18. Generic drugs: Current status and future potential

Neelima Mallam, Chandra Shekar Byalakere Rudraiah, Sushma Rudraswamy

Journal of Generic Medicines

Volume 13 Issue 2, doi: 10.1177/1741134317691803

19. Physicians’ perceptions towards brand medicine and its effect on prescribing: A narrative review

Mohsen Ali Murshid, Zurina Mohaidin

Journal of Generic Medicines

Volume 13 Issue 4, doi: 10.1177/1741134317709509

20. The pharmaceutical market and drug development prognosis in Japan: Current and future perspectives according to pharmacological classes

Shoyo Shibata, Takeshi Suzuki

Journal of Generic Medicines

Volume 14 Issue 2, doi: 10.1177/1741134317737344